| 1 |
34657601 | Non-invasive skin cholesterol testing: a potential proxy for LDL-C and apoB serum measurements. | 2021 Oct 17 |
1 |
| 2 |
32065359 | Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study. | 2020 Apr |
5 |
| 3 |
32411300 | Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials. | 2020 |
1 |
| 4 |
30688048 | Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus. | 2019 Oct |
4 |
| 5 |
31307833 | Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study. | 2019 Aug |
2 |
| 6 |
28392500 | Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin. | 2017 Jul |
3 |
| 7 |
25809021 | Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner. | 2015 May |
8 |
| 8 |
25816050 | Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin Treatment. | 2015 Jun |
2 |
| 9 |
26087958 | Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients. | 2015 Jun 19 |
2 |
| 10 |
24230979 | A meta-analysis of randomized head-to-head trials for effects of rosuvastatin versus atorvastatin on apolipoprotein profiles. | 2014 Jan 15 |
3 |
| 11 |
22204857 | Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients. | 2013 Jun 20 |
1 |
| 12 |
23237107 | Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial). | 2013 Feb 15 |
1 |
| 13 |
23494963 | Pharmacokinetic and pharmacodynamic profile of rosuvastatin in patients with end-stage renal disease on chronic haemodialysis. | 2013 Apr |
1 |
| 14 |
23600368 | Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidemia: a randomized pilot trial. | 2013 Jul |
1 |
| 15 |
21262787 | Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9. | 2011 Apr |
1 |
| 16 |
21349260 | Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease. | 2011 Jun |
2 |
| 17 |
21792295 | Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. | 2011 |
1 |
| 18 |
21859750 | Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome. | 2011 Oct |
1 |
| 19 |
21867445 | Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial. | 2011 Nov |
2 |
| 20 |
22101878 | Effect of rosuvastatin treatment on cholesterol efflux from human macrophages. | 2011 |
1 |
| 21 |
20146674 | [Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation]. | 2010 |
1 |
| 22 |
20147603 | Effects of atorvastatin 20 mg, rosuvastatin 10 mg, and atorvastatin/ezetimibe 5 mg/5 mg on lipoproteins and glucose metabolism. | 2010 Jun |
1 |
| 23 |
20417447 | Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study. | 2010 Mar |
3 |
| 24 |
20524719 | Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study. | 2010 |
1 |
| 25 |
19200542 | Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels. | 2009 Jul |
2 |
| 26 |
19474729 | Targets for LDL-lowering therapy. | 2009 Aug |
1 |
| 27 |
19900015 | Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA. | 2009 Nov |
2 |
| 28 |
23555376 | A Randomized Controlled Study to Compare the Effects of Rosuvastatin 5 mg and Atorvastatin 10 mg on the Plasma Lipid Profile in Japanese Patients with Hypercholesterolemia (ASTRO-2). | 2009 |
2 |
| 29 |
17416370 | Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome. | 2008 Mar |
5 |
| 30 |
18535816 | Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes. | 2008 Aug |
3 |
| 31 |
18691996 | Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health system perspective. | 2008 Jul |
2 |
| 32 |
18809153 | Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design. | 2008 Jun |
1 |
| 33 |
17367312 | Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes. | 2007 May |
1 |
| 34 |
16644314 | Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II. | 2006 May |
1 |
| 35 |
16950182 | Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial). | 2006 Sep 15 |
1 |
| 36 |
15642550 | Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia. | 2005 Jan 15 |
2 |
| 37 |
15823640 | Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study. | 2005 Apr 20 |
1 |
| 38 |
15910557 | Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study. | 2005 Jun |
2 |
| 39 |
16144509 | Rosuvastatin: a risk-benefit assessment for intensive lipid lowering. | 2005 Sep |
1 |
| 40 |
16193198 | Starting with rosuvastatin in primary hyperlipidemia--Is there more than lipid lowering? | 2005 Sep-Oct |
1 |
| 41 |
16307708 | LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study. | 2005 Nov |
1 |
| 42 |
15024300 | Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemia. | 2004 Mar |
1 |
| 43 |
15531001 | Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. | 2004 Sep |
2 |
| 44 |
12539816 | New dimension of statin action on ApoB atherogenicity. | 2003 Jan |
1 |
| 45 |
12646336 | Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups. | 2003 Mar 6 |
2 |
| 46 |
14636905 | Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia. | 2003 Dec 1 |
1 |
| 47 |
14644393 | Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia. | 2003 Dec |
2 |
| 48 |
12137448 | Statin therapy: rationale for a new agent, rosuvastatin. | 2002 Jun |
4 |
| 49 |
11524058 | Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia. | 2001 Sep 1 |
1 |